awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34064049-F063B53D-DA81-4511-BBB3-4C9828B6516F
Q34064049-F063B53D-DA81-4511-BBB3-4C9828B6516F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34064049-F063B53D-DA81-4511-BBB3-4C9828B6516F
Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase
P2860
Q34064049-F063B53D-DA81-4511-BBB3-4C9828B6516F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34064049-F063B53D-DA81-4511-BBB3-4C9828B6516F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09f0c60fe590cf781822bf69c071d8daff35fe22
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).